MetLife, Inc. (MET) Stock Forecast
MET analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.11 / 5 from 18 analysts
- Price target
- $107.38 average of analyst targets
- Upside to target
- +6.6% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $2.69
- 52-week range
- $67.70 – $100.76
MET analyst ratings
18 analystsNumber of analysts at each rating.
MET price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MET earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.76 | $2.55 | $2.92 | $2.37 | +16.3% | 16 |
| Current fiscal year (2026) | $10.21 | $10.00 | $10.45 | $8.83 | +15.6% | 17 |
| Next fiscal year (2027) | $11.16 | $10.76 | $11.61 | $10.21 | +9.3% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MET revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $19.97B | $19.20B | $20.65B | +11.6% | 7 |
| Current fiscal year (2026) | $79.73B | $77.98B | $82.57B | +1.1% | 10 |
| Next fiscal year (2027) | $83.16B | $80.20B | $84.98B | +4.3% | 10 |
MET EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MET revenue: reported and forecast
MET EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.53 | $2.58 | $2.55 | $2.68 | $2.76 | +8.8% | 8 up · 0 down |
| Current fiscal year (2026) | $9.88 | $9.95 | $10.00 | $10.14 | $10.21 | +3.3% | 9 up · 0 down |
| Next fiscal year (2027) | $11.02 | $11.09 | $11.13 | $11.15 | $11.16 | +1.3% | 4 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MET earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MET beat in 8 of 12.
What analysts expect from MET
18 analysts cover MetLife; their consensus rating is buy (4.11 on a 1–5 scale, where 5 is a strong buy). The average price target is $107.38, 6.6% above the latest close of $100.76. Analysts expect earnings of $10.21 per share for 2026, +15.6% from a year earlier. For 2027 the average estimate is $11.16 per share on revenue of $83.2 billion. MetLife beat the EPS estimate in 8 of the last 12 quarters.
Related: MET income statement, MET key metrics, MET chart. See the MET stock overview for the latest quote and news.
MET forecast FAQ
What is MetLife's price target?
The average analyst price target for MetLife is $107.38, 6.6% above the latest close of $100.76.
Is MetLife a buy, hold or sell?
Of 18 analysts covering MetLife, 8 rate it a strong buy, 5 a buy, 4 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is MetLife's EPS forecast?
Analysts forecast $10.21 per share for 2026 (range $10.00 to $10.45); for 2027 the estimate is $11.16.
What is MetLife's revenue forecast?
The average revenue estimate for 2026 is $79.7 billion, growth of 1.1%; for 2027 it is $83.2 billion.
When does MetLife report earnings?
MetLife is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $2.69.
Does MetLife usually beat earnings estimates?
MetLife reported EPS at or above the analyst estimate in 8 of the last 12 quarters.